Forget about .78 vs .88 vs 1.00; As a 2005 buyer at .04 a share, the story here keeps getting better.
IMHO, the registration of the new shares was planned to coincide with the FDA filing, soon to be followed by granting a large portion of those shares to Frank upon FDA approval. I think that CTUM showed Frank the technology and Ukrainian results, Frank said that he could get the technology approved by the FDA, and the parties worked out a share deal for compensation.
Also, Russian approval for LTC goes WAYYYYY beyond the promise of revenue from the procedure being performed in Russia. CTUM can now order production of the device to begin with no risk. When the FDA approval comes, the devices are manufactured and ready for immediate use. Until FDA approval, the devices are cleared and ready for use in Russia. It's a fantastic hedge, a win-win situation as it gives CTUM a chance to "beat the clock" a bit by being ready to go, even as the FDA deliberates.
Now it's time to focus on the CO2 separater, which is long, long overdue for some action.
